Giuseppe Lucisano
Overview
Explore the profile of Giuseppe Lucisano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
2034
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Cosmo S, Pontremoli R, Giandalia A, Manicardi V, Rocca A, Nicolucci A, et al.
J Nephrol
. 2024 Dec;
PMID: 39676127
Background: We evaluated the proportion of Type 2 diabetes (T2D) patients with chronic kidney disease (CKD) participating in the AMD (Association of Medical Diabetologists) Annals initiative who met the eligibility...
2.
Prattichizzo F, Veronesi V, Rigoni M, La Grotta R, Pellegrini V, Lucisano G, et al.
Diabetes Obes Metab
. 2024 Oct;
27(2):490-500.
PMID: 39468384
Aim: Intraindividual body weight variability (BWV), that is, the degree of weight fluctuations over time, is associated with an increased risk of cardiovascular diseases (CVDs) in multiple settings. The impact...
3.
Russo G, Nicolucci A, Lucisano G, Rossi M, Ceriello A, Prattichizzo F, et al.
Diabetes
. 2024 Oct;
74(1):75-81.
PMID: 39418322
Article Highlights:
4.
Simone M, Lucisano G, Guerra T, Paolicelli D, Rocca M, Morra V, et al.
J Neurol
. 2024 Aug;
271(10):6782-6790.
PMID: 39179712
Background: To compare Expanded Disability Status Scale (EDSS) trajectories over time between Multiple Sclerosis (MS) groups with pediatric (POMS), adult (AOMS) and late (LOMS) onset, and between patients with and...
5.
Russo G, Giandalia A, Lucisano G, Rossi M, Piscitelli P, Pontremoli R, et al.
Eur J Intern Med
. 2024 Aug;
130:123-129.
PMID: 39129121
Background: Diabetic kidney disease is the most common cause of end-stage kidney disease (ESKD) in the western world. Rapid estimated glomerular filtration rate (eGFR) decline is an independent predictor of...
6.
Russo G, Manicardi V, Rocca A, Nicolucci A, Giandalia A, Lucisano G, et al.
Metab Syndr Relat Disord
. 2024 Aug;
22(9):661-668.
PMID: 39088376
Familial chylomicronemia syndrome (FCS) is a rare inherited condition due to lipoprotein lipase deficiency, characterized by hyperchylomicronemia and severe hypertriglyceridemia. Diagnosis is often delayed, thus increasing the risk of acute...
7.
Iaffaldano P, Lucisano G, Guerra T, Paolicelli D, Portaccio E, Inglese M, et al.
Ann Clin Transl Neurol
. 2024 Jul;
11(8):2008-2015.
PMID: 38970214
Objective: No direct comparisons of the effect of natalizumab and ocrelizumab on progression independent of relapse activity (PIRA) and relapse-associated worsening (RAW) events are currently available. We aimed to compare...
8.
Glaser A, Butzkueven H, van der Walt A, Gray O, Spelman T, Zhu C, et al.
J Neurol
. 2024 Apr;
271(6):3616-3624.
PMID: 38561543
Background: The Big Multiple Sclerosis Data (BMSD) network ( https://bigmsdata.org ) was initiated in 2014 and includes the national multiple sclerosis (MS) registries of the Czech Republic, Denmark, France, Italy,...
9.
Iaffaldano P, Lucisano G, Guerra T, Patti F, Cocco E, De Luca G, et al.
J Neurol
. 2023 Dec;
271(3):1150-1159.
PMID: 38135850
Background: Active relapsing-remitting (RR) and secondary progressive (SP) multiple sclerosis (MS) are currently defined as "relapsing MS" (RMS). The aim of this cross-sectional study was to assess drivers of treatment...
10.
Mameli C, Rigamonti A, Felappi B, Nicolucci A, Lucisano G, Baresi S, et al.
Diabetes Technol Ther
. 2023 Nov;
26(2):112-118.
PMID: 38032850
Few data are available in children with type 1 diabetes using automated insulin delivery systems during physical activity (PA). We evaluated the time in range (TIR) during 2-h of outdoor...